Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
QIAGEN logo — Provider of molecular Sample to Insight solutions

QIAGEN

Provider of molecular Sample to Insight solutions

Founded 1984 The Netherlands The Netherlands 5488 employees IPO Total: $504.60M

General Information

Company Name QIAGEN
Founded Year 1984
Location The Netherlands The Netherlands +37
Employees 5488
Funding Stage IPO
Social

Get notified when QIAGEN moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About QIAGEN

QIAGEN, founded in 1984, is a dominant player in the biomolecular industry with its mission encapsulated in the slogan: Provider of molecular Sample to Insight solutions. Headquartered in The Netherlands, the company specializes in isolating and processing essential biomolecules such as DNA, RNA, and proteins from various samples.

The company's technologies include advanced assay methods, bioinformatics software, and seamless automation solutions, collectively facilitating the transformation of molecular data into actionable insights. Serving over 500,000 clients globally, QIAGEN caters to sectors like Molecular Diagnostics and Life Sciences, supporting endeavors in human healthcare and industrial applications.

As of the end of 2021, QIAGEN employed over 6,000 individuals across more than 35 locations worldwide. The company’s recent financial momentum was underscored by a significant $500.00M Post IPO Convertible investment on 01 September 2024, indicating robust investor confidence in its growth trajectory.

Taxonomy: Molecular Sample to Insight solutions, Sample technologies, DNA/RNA/Proteins isolation, Assay technologies, Bioinformatics software, Automation solutions, Molecular Diagnostics, Life Sciences, Human healthcare, Pharma R&D, Forensics, Food safety testing, Veterinary medicine, Pharmaceutical research, Biomolecular analysis

Services & Products

IVD Sample Extraction Automation
Clinical Nucleic Acid Extraction
Digital PCR Systems
Hybrid Capture Technology
MiRNA Discovery and Validation

Target Customers

Clinical Labs Biotech and Pharma Companies Research Institutions Forensic Labs Oncology Researchers

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Post Ipo Convertible •••••• - 01 Sep 2024
Post Ipo Equity •••••• 1
Investor
01 Aug 2023
Grant •••••• 2 •••• •••• 01 Oct 2021
Grant •••••• 1 •••• •••• 01 Mar 2020
IPO •••••• - 01 Jul 1996

View All 7 Funding Rounds

QIAGEN Alternatives & Competitors

View All Alternatives
QIAGEN vs
Norgen Biotek
Norgen Biotek Canada

Facilitating Excellence in Research

84 employees
Biotechnology, Life Sciences
Compare QIAGEN vs Norgen Biotek
QIAGEN vs
Isohelix
Isohelix United Kingdom

Manufacturer of high performance Buccal, Saliva and Microbiome DNA & RNA collection, Stabilization a...

5 employees
Biotechnology, Manufacturing
QIAGEN vs
BIOMOLE SRL
BIOMOLE SRL Italy

An Academic spin-off contextualised in the transfer technology-III Mission of the University of Turi...

2 employees
Biotechnology, Health Care
Also compare with: QIAGEN vs Protein Discovery Protein Discovery QIAGEN vs Lybe Scientific AS Lybe Scientific AS View all alternatives

FAQ About QIAGEN

Provider of molecular Sample to Insight solutions
QIAGEN was founded in 1984.
QIAGEN is headquartered in The Netherlands.
QIAGEN has approximately 5488 employees.
QIAGEN has completed 7 funding rounds, raising a total of $504.60M. The latest funding stage is IPO.
QIAGEN offers: IVD Sample Extraction Automation, Clinical Nucleic Acid Extraction, Digital PCR Systems, Hybrid Capture Technology, MiRNA Discovery and Validation.
Top alternatives and competitors to QIAGEN include Norgen Biotek, Isohelix, BIOMOLE SRL, Protein Discovery, Lybe Scientific AS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
QIAGEN and Norgen Biotek are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors QIAGEN and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes